With over 600,000 average monthly users on the HotCopper forums, trending discussions can influence market activity for Australian stocks. This daily column highlights the stocks drawing the most attention from traders.

Koonenberry Gold Completes Gundagai Acquisition

Koonenberry Gold (ASX:KNB) advanced after completing its acquisition of 100% of the issued capital of Gilmore Minerals, which holds the high-grade Gundagai gold-copper project. The company stated that the acquisition significantly strengthens its position within the Lachlan Fold Belt of New South Wales, a province that hosts several major porphyry and orogenic gold deposits and remains one of Australia's most active exploration regions for gold and copper.

The Gundagai project encompasses four target domains — Johnston's Hill, Big Ben-Princess Marina, Snowball-Califat, and Kimo — comprising a contiguous tenement package considered highly prospective for epithermal-porphyry Au-Cu, intrusion-related, and orogenic gold systems.

"Completing the Gundagai acquisition provides Koonenberry with a 485 sq. km expansion of our Lachlan Fold Belt footprint and represents a Tier-1 'camp-scale' opportunity with near-term drill targets," executive chairman Paul Harris said.

KNB was up 13.0% to 2.6¢ in early trade.

Legacy Minerals Identifies New Gold-Silver Targets at Mascotte

Legacy Minerals Holdings (ASX:LGM) drew investor interest after ground-based induced polarisation (IP) geophysical surveys defined a large, untested gold-silver target at the Mascotte prospect within its Mt Carrington project in New South Wales. IP surveys are widely used in mineral exploration to detect subsurface chargeable materials, often associated with sulfide mineralisation, and can help prioritise drill targets in areas where mineralisation may not be visible at surface.

"This new geophysical survey at Mascotte has delivered exactly what we were hoping to see: several large, strong chargeability targets sitting right alongside gold-silver mineralisation we have already intersected yet have never been drill tested," CEO and managing director Christopher Byrne said.

"The strongest anomalies exceed 30 mV/V, and the 3D modelling shows they are continuous between our survey lines and remain open along strike. These are the kinds of untested targets that can lead to the next major discovery at Mt Carrington, and all are outside the existing 1.6 Moz gold-equivalent mineral resource. Drilling is already underway, and testing these targets is a priority in the current program."

LGM was up 12.0% to 14.0¢ at the time of publication.

LTR Pharma Reports Positive SPONTAN Real-World Data

LTR Pharma (ASX:LTP) announced positive outcomes from a retrospective real-world cohort of 147 treatment-experienced men prescribed SPONTAN, the company's rapid-onset intranasal vardenafil spray, in routine Australian clinical practice. Vardenafil, the active ingredient, is also used in conventional oral ED medications and belongs to the same class of PDE5 inhibitors as sildenafil and tadalafil.

Executive chairman Lee Rodne said the real-world findings indicate that SPONTAN may provide an alternative treatment option for men who report inadequate results with conventional oral ED therapies such as sildenafil (Viagra) and tadalafil (Cialis).

"We regard this as an important real-world dataset for LTR Pharma. The 93% response among men seeking greater convenience reinforces our belief that the opportunity for SPONTAN and ROXUS extends beyond patients who simply fail oral tablets — it includes men seeking greater spontaneity and control over their treatment," Rodne said.

"The finding that nearly two-thirds of post-prostatectomy patients reported improved erectile hardness and/or achieving penetration is particularly encouraging given the recognised difficulty in treating ED following prostate cancer surgery. Oral therapies may provide limited benefit for some men and patients may ultimately progress to invasive treatments such as penile injections. We believe rapid, non-invasive intranasal treatment has the potential to address an important unmet need in this clearly identifiable patient population."

LTP jumped 12.8% to 53.0¢.

Broader Market

The S&P/ASX 200 gained 26.70 points, or 0.29%, to 9,259.30. Over the last five days, the index has risen 1.24% and currently sits 0.40% below its 52-week high.

IEA Report: Copper and Lithium Gaps Narrow, Cobalt Risks Emerge

According to a new report from the International Energy Agency (IEA), gaps between projected demand and anticipated supply over the next decade have narrowed for copper and lithium, though new risks have emerged for cobalt due to policy shifts in major producing nations.

The IEA states that, based on the current project pipeline, supply deficits for copper and lithium are set to persist through 2035, although the outlook has somewhat improved. For copper, the projected supply deficit in 2035 has narrowed from approximately 30% in last year's IEA Outlook to 25%, as new projects advance — particularly in the Democratic Republic of the Congo (DRC) and Zambia.

By contrast, a projected supply gap has emerged for cobalt following the DRC's introduction of a new export quota. The DRC accounts for the majority of global cobalt mine production, making it a single point of exposure for supply disruption. The IEA notes that this development underscores how policy changes by major producers can rapidly reshape the global supply outlook in markets characterised by high levels of geographic concentration.